精神病并发症对肝硬化结果的影响:一种倾向匹配的队列分析
Muhammad Ali Ibrahim Kazi1, Mahnoor Sarfraz2, Siraj Ahmad2
1Department of Medicine, Anne Arundel Medical Center, Annapolis, Maryland, USA.
概括
肝硬化和情绪障碍患者面临更高的严重并发症,肝移植和死亡风险. 综合精神病治疗对于有效管理这些患者至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 精神病学是一个精神病学.
- 临床研究 临床研究
背景情况:
- 肝硬化是一种严重的肝病,影响生活质量.
- 情绪障碍在慢性肝病中很普遍,可能会恶化结果.
- 情绪障碍对肝硬化进展和并发症的确切影响尚不清楚.
研究的目的:
- 研究心情障碍与肝硬化患者的临床结果之间的关联.
- 为了比较心情障碍和没有心情障碍的肝硬化患者之间的并发症率,移植可能性和死亡率.
主要方法:
- 使用 TriNetX 全球研究网络进行的回顾性队列研究.
- 包括被诊断患有肝硬化的成年患者.
- 倾向性得分匹配 (1:1) 用于控制人口学变量.
主要成果:
- 患有情绪障碍的肝硬化患者表现出明显更高的水出血,,自发性细菌周周炎,肝脑病和肝综合征.
- 在情绪障碍患者中,肝移植的可能性增加和全因死亡率的适度增加被观察到.
- 所有报告的并发症都显示出统计学意义 (p < 0.001).
结论:
- 情绪障碍与肝硬化中肝脏脱补偿事件的增加有关.
- 伴随性情绪障碍与肝硬化患者的更高的移植率和死亡率有关.
- 强调综合精神病治疗的必要性以及对这一群体的进一步前性研究.
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
732
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
732
Psychosis: Goals of Pharmacotherapy
645
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
645
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
318
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
318
Stress and Mental Health
1.0K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
1.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
304
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
304
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
